Gene · 9294
Papers2,171
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,171
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-target regulation of intestinal microbiota by berberine to improve type 2 diabetes mellitus. | Front Endocrinol (Lausanne) | 2022 | 36465656 | PubTator, text mining | PubMed |
| Triptolide Inhibits the Biological Processes of HUVECs and HepG2 Cells via the Serine Palmitoyltransferase Long Chain Base Subunit 2/Sphingosine-1-Phosphate Signaling Pathway. | Dis Markers | 2022 | 36438896 | PubTator, text mining | PubMed |
| S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review. | Ther Adv Neurol Disord | 2022 | 36437849 | PubTator, text mining | PubMed |
| Bile Acids: Physiological Activity and Perspectives of Using in Clinical and Laboratory Diagnostics. | Molecules | 2022 | 36431930 | PubTator, text mining | PubMed |
| Sphingosine 1-Phosphate and Apolipoprotein M Levels and Their Correlations with Inflammatory Biomarkers in Patients with Untreated Familial Hypercholesterolemia. | Int J Mol Sci | 2022 | 36430543 | PubTator, text mining | PubMed |
| Sphingosine 1-phosphate mediates adiponectin receptor signaling essential for lipid homeostasis and embryogenesis. | Nat Commun | 2022 | 36418331 | PubTator, text mining | PubMed |
| Correction to "Rational Design, Synthesis, and Biological Evaluation of Novel S1PR2 Antagonists for Reversing 5-FU-Resistance in Colorectal Cancer". | J Med Chem | 2022 | 36417665 | PubTator, text mining | PubMed |
| Identification of six hub genes in mantle cell lymphoma patients with BTKi resistance. | Ann Transl Med | 2022 | 36388812 | PubTator, text mining | PubMed |
| Intestinal Flora Derived Metabolites Affect the Occurrence and Development of Cardiovascular Disease. | J Multidiscip Healthc | 2022 | 36388628 | PubTator, text mining | PubMed |
| Genetic variants associated with circulating liver injury markers in Mexican Americans, a population at risk for non-alcoholic fatty liver disease. | Front Genet | 2022 | 36386790 | PubTator, text mining | PubMed |
| Intrahepatic cholestasis of pregnancy can increase the risk of metabolic disorders: A meta-analysis. | J Med Biochem | 2022 | 36381082 | PubTator, text mining | PubMed |
| Pathogenic Role of the Sphingosine 1-Phosphate (S1P) Pathway in Common Gynecologic Disorders (GDs): A Possible Novel Therapeutic Target. | Int J Mol Sci | 2022 | 36362323 | PubTator, text mining | PubMed |
| Linking Nonalcoholic Fatty Liver Disease and Brain Disease: Focusing on Bile Acid Signaling. | Int J Mol Sci | 2022 | 36361829 | PubTator, text mining | PubMed |
| Advancements on the Multifaceted Roles of Sphingolipids in Hematological Malignancies. | Int J Mol Sci | 2022 | 36361536 | PubTator, text mining | PubMed |
| Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer. | Int J Mol Sci | 2022 | 36361531 | PubTator, text mining | PubMed |
| Nogo-A Regulates the Fate of Human Dental Pulp Stem Cells toward Osteogenic, Adipogenic, and Neurogenic Differentiation. | Cells | 2022 | 36359811 | PubTator, text mining | PubMed |
| Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries. | J Biomed Sci | 2022 | 36357929 | PubTator, text mining | PubMed |
| Endogenous reparative pluripotent Muse cells with a unique immune privilege system: Hint at a new strategy for controlling acute and chronic inflammation. | Front Pharmacol | 2022 | 36339573 | PubTator, text mining | PubMed |
| Clonorchis sinensis infection induces hepatobiliary injury via disturbing sphingolipid metabolism and activating sphingosine 1-phosphate receptor 2. | Front Cell Infect Microbiol | 2022 | 36339341 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals different signatures of mesenchymal stromal cell pluripotent-like and multipotent populations. | iScience | 2022 | 36339265 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9294/papers?page=20